cell and gene therapy
cell and gene therapy
Revolutionizing Cell and Gene Therapy: Challenges and Opportunities
Redefining Cell and Gene Therapy Navigation 📰 explores the challenges and opportunities in this rapidly evolving sector 🧬. It emphasizes the need for improved regulatory frameworks and collaboration 💼💪🏼🌍.
Gene Therapy Supplier Raises £7M for Breakthrough Technology
💰 Gene therapy supplier MIP Discovery secures £7M in funding to boost commercialization of synthetic affinity reagents in cell and gene therapy. 🧬🔬👥
Bio-Techne’s CGT Boosts Growth: Q2 Success
📣 Bio-Techne Q2: CGT is a major growth driver! 🧪 Increasing demand, 💼 expanding capacity, and 💰 future growth expected.
Revolutionary Gene Therapy for Heart Failure: Promising Results!
💉 Bayer's AskBio unit begins Phase II testing of gene therapy AB-1002 for heart failure patients. Promising results!
Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing
📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼
AstraZeneca’s $300M Expansion Ignites Cell and Gene Therapy Revolution
AstraZeneca invests $300m in new research facility in Cambridge, UK to advance cell and gene therapies. 💉🔬💼🔍👥
Lonza’s Upcoming Approvals Will Revolutionize CGT Biz in 2024
💼Lonza is looking to strengthen its cell and gene therapy business through upcoming approvals in 2024. 🌟🔬💉💪📈🔒💼🌐
Revolutionary Packaging Method Cuts Costs & Risks in Lentiviral Manufacturing
📌 Dive into the world of lentiviral manufacturing with the LV Edge Packaging! 💰💊 Reduce costs and risks for better therapies! 🚀✨
Revolutionary Startup Aims to Transform Cell and Gene Therapies
📰 Frustration with CDMOs fuels ambition for advanced therapy startup GDMC, offering end-to-end solutions for cell and gene therapies. 💡💪🌱🧬
Mastering GMP Manufacturing of Gene Therapy Nanoparticles
📝 Navigating GMP Manufacturing of mRNA-Lipid Nanoparticles explores challenges, technologies, and regulations in gene therapy production. 🔬💡🌍
